{"id":"https://openalex.org/W2137920545","doi":"https://doi.org/10.1002/j.1875-9114.2011.01049.x","title":"Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin","display_name":"Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-24","ids":{"openalex":"https://openalex.org/W2137920545","doi":"https://doi.org/10.1002/j.1875-9114.2011.01049.x","mag":"2137920545","pmid":"https://pubmed.ncbi.nlm.nih.gov/22531940"},"language":"en","primary_location":{"id":"doi:10.1002/j.1875-9114.2011.01049.x","doi":"https://doi.org/10.1002/j.1875-9114.2011.01049.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1875-9114.2011.01049.x","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2137920545"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010084322","display_name":"Jeremy W. Vandiver","orcid":"https://orcid.org/0000-0002-7596-0183","observed_orcids":["https://orcid.org/0000-0002-7596-0183"]},"institutions":[{"id":"https://openalex.org/I2801439542","display_name":"Exempla Saint Joseph Hospital","ror":"https://ror.org/02z8mgx68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801439542"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy W. Vandiver","raw_affiliation_strings":["Department of Pharmacy Exempla Saint Joseph Hospital Denver Colorado","Department of Pharmacy, Exempla Saint Joseph Hospital, 1835 Franklin Street, Denver, CO 80218, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Exempla Saint Joseph Hospital Denver Colorado","institution_ids":["https://openalex.org/I2801439542"]},{"raw_affiliation_string":"Department of Pharmacy, Exempla Saint Joseph Hospital, 1835 Franklin Street, Denver, CO 80218, USA","institution_ids":["https://openalex.org/I2801439542"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023387784","display_name":"Thomas G. Vondracek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801439542","display_name":"Exempla Saint Joseph Hospital","ror":"https://ror.org/02z8mgx68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801439542"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas G. Vondracek","raw_affiliation_strings":["Department of Pharmacy, Exempla Saint Joseph Hospital, Denver, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Exempla Saint Joseph Hospital, Denver, Colorado","institution_ids":["https://openalex.org/I2801439542"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023387784"],"corresponding_institution_ids":["https://openalex.org/I2801439542"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.222,"has_fulltext":false,"cited_by_count":265,"citation_normalized_percentile":{"value":0.75034965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"32","issue":"6","first_page":"546","last_page":"558"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.07649999856948853,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/unfractionated-heparin","display_name":"unfractionated heparin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anticoagulation-monitoring","display_name":"anticoagulation monitoring","score":0.9539999961853027},{"id":"https://openalex.org/keywords/protamine-titration","display_name":"protamine titration","score":0.9599999785423279},{"id":"https://openalex.org/keywords/laboratory-variability","display_name":"laboratory variability","score":0.4970000088214874},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.8725917339324951},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.7592530846595764},{"id":"https://openalex.org/C2780835560","wikidata":"https://www.wikidata.org/wiki/Q5449573","display_name":"Protamine","level":3,"score":0.5812805891036987},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5023350715637207},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39353659749031067},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3593384623527527},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.3063221573829651},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.22714939713478088},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21719756722450256}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010314","descriptor_name":"Partial Thromboplastin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015951","descriptor_name":"Factor Xa","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1875-9114.2011.01049.x","doi":"https://doi.org/10.1002/j.1875-9114.2011.01049.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1875-9114.2011.01049.x","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:22531940","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22531940","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W1527283637","https://openalex.org/W1823591369","https://openalex.org/W1964539948","https://openalex.org/W1972706485","https://openalex.org/W1981028815","https://openalex.org/W1981859573","https://openalex.org/W2003915795","https://openalex.org/W2013537866","https://openalex.org/W2016828498","https://openalex.org/W2018710690","https://openalex.org/W2025513998","https://openalex.org/W2031030340","https://openalex.org/W2031219338","https://openalex.org/W2038483995","https://openalex.org/W2039562879","https://openalex.org/W2039989814","https://openalex.org/W2050424823","https://openalex.org/W2051551497","https://openalex.org/W2055054879","https://openalex.org/W2056549587","https://openalex.org/W2059420605","https://openalex.org/W2073325230","https://openalex.org/W2080318130","https://openalex.org/W2082107448","https://openalex.org/W2082819314","https://openalex.org/W2085029573","https://openalex.org/W2085422645","https://openalex.org/W2086176243","https://openalex.org/W2094832670","https://openalex.org/W2106083574","https://openalex.org/W2109895213","https://openalex.org/W2116882868","https://openalex.org/W2138679315","https://openalex.org/W2146523364","https://openalex.org/W2164196526","https://openalex.org/W2170612781","https://openalex.org/W2170857716","https://openalex.org/W2171355746","https://openalex.org/W2214576528","https://openalex.org/W2259267827","https://openalex.org/W2272360610","https://openalex.org/W2276837945","https://openalex.org/W2308016530","https://openalex.org/W2313056357","https://openalex.org/W2329761741","https://openalex.org/W2400234549","https://openalex.org/W2402986535","https://openalex.org/W2411965087","https://openalex.org/W2433599465","https://openalex.org/W2461345642","https://openalex.org/W2589004289","https://openalex.org/W4233745943","https://openalex.org/W4241555481","https://openalex.org/W4243760412","https://openalex.org/W4243820579","https://openalex.org/W4299916133","https://openalex.org/W4319718799"],"related_works":["https://openalex.org/W2138679315","https://openalex.org/W3116287458","https://openalex.org/W2041829143","https://openalex.org/W1833914063","https://openalex.org/W2973722611","https://openalex.org/W6963685000","https://openalex.org/W2463444425","https://openalex.org/W2919910170","https://openalex.org/W2528577342","https://openalex.org/W2164196526"],"abstract_inverted_index":{"Intravenous":[0],"unfractionated":[1],"heparin":[2,105,141],"(UFH)":[3],"remains":[4],"an":[5],"important":[6],"therapeutic":[7],"agent,":[8],"particularly":[9],"in":[10,58,73],"the":[11,17,25,41,44,51,59,96,127,131,148,153,190,196,205,220,226],"inpatient":[12],"setting,":[13],"for":[14,212],"anticoagulation.":[15],"Historically,":[16],"activated":[18],"partial":[19],"thromboplastin":[20],"time":[21],"(aPTT)":[22],"has":[23,38,61],"been":[24],"primary":[26],"laboratory":[27,78],"test":[28,37],"used":[29],"to":[30,67,79,86,139,159,166,239,245],"monitor":[31],"and":[32,43,81,186,223,230,234],"adjust":[33],"UFH.":[34,214],"The":[35],"aPTT":[36,74,97,128,165],"evolved":[39],"since":[40],"1950s,":[42],"historical":[45],"goal":[46,98],"range":[47,99],"of":[48,64,71,107,130,133,195,225],"1.5-2.5":[49],"times":[50],"control":[52],"aPTT,":[53,227],"which":[54],"first":[55],"gained":[56],"favor":[57,65],"1970s,":[60],"fallen":[62],"out":[63],"due":[66],"a":[68,89,103,162,172,209,236],"high":[69],"degree":[70],"variability":[72],"readings":[75],"from":[76,83,152,164],"one":[77,84],"another,":[80],"even":[82],"reagent":[85],"another.":[87],"As":[88],"result,":[90],"it":[91,200],"is":[92,208],"now":[93],"recommended":[94],"that":[95,121,161,177,204],"be":[100,202],"based":[101],"on":[102],"corresponding":[104],"concentration":[106],"0.2-0.4":[108],"unit/ml":[109,115],"by":[110,116],"protamine":[111,231],"titration":[112,232],"or":[113],"0.3-0.7":[114],"antifactor":[117,143,167,197,206,228],"Xa":[118,144,168,198,207],"assay.":[119],"Given":[120,189],"several":[122],"biologic":[123],"factors":[124],"can":[125,201],"influence":[126],"independent":[129],"effects":[132],"UFH,":[134],"many":[135],"institutions":[136],"have":[137,157],"transitioned":[138],"monitoring":[140,169,213,248],"with":[142],"levels,":[145],"rather":[146],"than":[147],"aPTT.":[149],"Clinical":[150],"data":[151],"last":[154],"10-20":[155],"years":[156],"begun":[158],"show":[160],"conversion":[163],"may":[170],"offer":[171],"smoother":[173],"dose-response":[174],"curve,":[175],"such":[176],"levels":[178],"remain":[179],"more":[180],"stable,":[181],"requiring":[182],"fewer":[183],"blood":[184],"samples":[185],"dosage":[187],"adjustments.":[188],"minimal":[191],"increased":[192],"acquisition":[193],"cost":[194],"reagents,":[199],"argued":[203],"cost-effective":[210],"method":[211],"In":[215],"this":[216],"review,":[217],"we":[218],"discuss":[219],"relative":[221],"advantages":[222],"disadvantages":[224],"Xa,":[229],"tests,":[233],"provide":[235],"clinical":[237],"framework":[238],"guide":[240],"practitioners":[241],"who":[242],"are":[243],"seeking":[244],"optimize":[246],"UFH":[247],"within":[249],"their":[250],"own":[251],"institutions.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2137920545","counts_by_year":[{"year":2026,"cited_by_count":28},{"year":2025,"cited_by_count":26},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":29},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":30},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
